EcoDrugPlus

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSOTSG00005002178
Gene Symbol: PSMA1
1 Cross references
199 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSOTSG00005018255
Gene Symbol: PSMA1
3 Cross references
204 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSOTSG00005041231
Gene Symbol: PSMA2
1 Cross references
264 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSOTSG00005032946
Gene Symbol: PSMA4
1 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSOTSG00005010697
Gene Symbol: PSMA4
1 Cross references
166 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSOTSG00005000827
Gene Symbol: PSMA5
3 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSOTSG00005009303
Gene Symbol: PSMA6
1 Cross references
265 Possible Orthologues:

Proteasome 20s Subunit Alpha 6b

Ensembl ID : ENSOTSG00005032296
Gene Symbol: PSMA6B
1 Cross references
262 Possible Orthologues:

Proteasome 20s Subunit Alpha 6b

Ensembl ID : ENSOTSG00005003898
Gene Symbol: PSMA6B
1 Cross references
264 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSOTSG00005013358
Gene Symbol: PSMA7
1 Cross references
156 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSOTSG00005015767
Gene Symbol: PSMA7
1 Cross references
157 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSOTSG00005046659
Gene Symbol: PSMA8
1 Cross references
166 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).